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FAST TRACK
  
What is the best test for 
peripheral vascular disease?
Evidence-based answer
An ankle-brachial index is best for 
evaluating patients with symptoms of 
claudication (strength of recommendation 
[SOR]: B, multiple cohort studies). That 
said, duplex ultrasonography or magnetic 
resonance angiography may be a preferable 
fi rst step if immediate revascularization 
appears necessary (SOR: C, expert 
consensus and case reports). In addition, 
a toe-brachial index may be superior to an 
ankle-brachial index for evaluating elderly 
and diabetic patients (SOR: C, expert 
consensus and case reports). 
 After considering the accuracy, cost, 
and risk of available tests, an appropriate 
stepwise approach begins with a complete 
history and targeted physical examination 
(palpation of pulses) (SOR: B, consistent 
cohort studies); then obtain an ankle-
brachial index to confi rm the diagnosis. 
Clinical commentary
Ankle-brachial index: An underused test 
In my experience, the ankle-brachial index 
is often underused because of a lack of 
time, equipment, and proper training. 
Nonetheless, as the evidence makes clear, 
this test is the best approach for patients 
with symptoms of claudication. 
 Another option you may want to 
consider is the Edinburgh Claudication 
Questionnaire (FIGURE). This tool has 
a strong positive predictive value and 
positive likelihood ratio and may allow for a 
presumptive diagnosis, especially among 
patients with signifi cant risk factors such 
as diabetes, hypertension, hyperlipidemia, 
coronary artery disease, and tobacco use. 
It has limitations, though, which are detailed 
in this Clinical Inquiry. 
 For initial management of peripheral 
vascular disease (PVD), you can recommend 
lifestyle modifi cation, antiplatelet agents, and 
aggressive control of blood glucose, blood 
pressure, and lipids without further testing. 
Reserve Doppler ultrasound and magnetic 
resonance angiography for patients who 
require revascularization or don’t respond to 
medical therapy. 
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The toe-brachial 
index may be 
superior to an 
ankle-brachial 
index for 
evaluating 
elderly and 
diabetic patients 
❚ Evidence summary
PVD is a progressive atherosclerotic nar-
rowing of arteries in the extremities. The 
prevalence increases with age—it is less 
than 1% in people between 40 and 49 
years of age and 15% in people 70 years 
and older.1,2 Risk factors are the same as 
for coronary artery disease.1
Weighing your options
Methods for evaluating patients for PVD 
include medical history, physical ex-
amination (inspection of the extremities 
and palpation of peripheral pulses), and 
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ancillary testing (ankle-brachial index, 
duplex ultrasound, and magnetic reso-
nance imaging with contrast, and angi-
ography). The toe-brachial index may be 
useful in the elderly and patients with ad-
vanced diabetes because noncompressible 
vasculature in these patients may render 
the ankle-brachial index unreliable.3 
The TABLE lists the sensitivities, speci-
fi cities, positive predictive values, and 
likelihood ratios for commonly used 
tests.3-8 The calculations assume periph-
eral vascular disease to have a prevalence 
of 14% among people older than 60 years, 
based on pooled results from several epi-
demiologic studies.1
A questionnaire-based history of 
claudication (the Edinburgh Claudica-
tion Questionnaire) has been shown to 
have a high positive predictive value and 
likelihood ratio for PVD; physical exami-
nation techniques appear to be less pre-
dictive.4-7 However, the gold standard in 
the questionnaire study was “clinician de-
termination,” which carries a risk of sub-
jectivity and lack of testing independence 
that may make the test appear more ac-
curate than it is in typical application.
A stepwise approach
After balancing the accuracy, cost, and risk 
of available tests, an appropriate stepwise 
approach to evaluation for PVD is: 
First, do a complete history and tar-
geted physical examination (palpation of 
pulses).
Next, obtain an ankle-brachial index 
to confi rm the diagnosis. 
Then, proceed directly to either duplex 
ultrasonography or magnetic resonance 
angiography when revascularization is 
clearly needed.9
The major advantages of the ankle-
brachial index include low cost and non-
invasiveness (low potential for harm). 
However, it doesn’t detect proximal an-
eurysms or PVD distal to the ankle, and 
it may be diffi cult to perform on patients 
with noncompressible distal vasculature. 
Adequately evaluating such patients may 
require invasive testing. 
Recommendations
The US Preventive Services Task Force 
recommends against (D recommenda-
tion) any screening tests for PVD in pa-
tients without symptoms.10 The Ameri-
can College of Cardiology gives a class I 
recommendation (tests for which there is 
evidence or general agreement that a pro-
cedure is useful, benefi cial, or effective) to 
the ankle-brachial index as the baseline 
diagnostic tool for establishing periph-
eral vascular disease, except in elderly 
The Edinburgh Claudication 
Questionnaire
1.  Do you get a pain or discomfort in your leg(s) when you walk? 
 ❑ Yes ❑ No ❑ I am unable to walk
    If you answered “Yes” to question (1), please answer the following 
    questions. Otherwise, you need not continue.
2.  Does this pain ever begin when you are standing still 
or sitting?
❑ Yes ❑ No
3.  Do you get it if you walk uphill or hurry?
❑ Yes ❑ No
4.  Do you get it when you walk at an 
ordinary pace on the level?
❑ Yes  ❑ No
5.  What happens to it if you stand still?
❑ Usually continues more than 10 minutes.
❑ Usually disappears in 10 minutes or less.
6.  Where do you get this pain or discomfort?
Mark the place(s) with an “x” on the diagram below.
Defi nition of positive classifi cation requires all of the following responses: “Yes” to 
(1), “No” to (2), “Yes” to (3), and “usually disappears in 10 minutes or less” to (5); 
grade 1 = “No” to (4) and grade 2 = “Yes” to (4). If these criteria are fulfi lled, a defi nite 
claudicant is one who indicates pain in the calf, regardless of whether pain is also 
marked in other sites; a diagnosis of atypical claudication is made if pain is indicated 
in the thigh or buttock, in the absence of any calf pain. Patients should not be 
considered to have claudication if pain is indicated in the hamstrings, feet, shins, 
joints, or appears to radiate, in the absence of any pain in the calf. 
Source: Leng GC, Fowkes FG.4 Adapted with permission. 
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Commonly used tests for peripheral vascular disease
TEST
COMPARISON/
STANDARD
SENSITIVITY %
(95% CI, 
IF REPORTED)
SPECIFICITY % 
(95% CI, 
IF REPORTED) PPV* LR- LR+
REIMBURSEMENT 
ESTIMATE† 
MEDICAL HISTORY
CPT 
CODE
ESTIMATED 
COST
Edinburgh 
Claudication 
Questionnaire4
Claudication 
by clinician 
assessment
91.0 
(88.1-94.5)
99.0
(98.9-100.0)
0.955 0.09 91.0 99203 $87.29
PHYSICAL EXAMINATION
Color abnormality of extremity 
skin (pale, red, or blue)5
ABI<0.9 35.0 87.0 0.305 0.75 2.7 99203 $87.29
Cool skin unilaterally5 ABI<0.9 10.0 98.0 0.449 0.92 5.0 99203 $87.29
Any abnormal pulse 
by palpation6
Multiple 
criteria‡
76.9 86.4 0.479 0.27 5.7 99203 $87.29
Presence of femoral bruit6 Multiple 
criteria‡
20.0 95.7 0.431 0.84 4.7 99203 $87.29
Absent pedal pulses
(dorsalis pedis and 
posterior tibial)7
ABI<0.9 63.0 99.0 0.912 0.37 63.9 99203 $87.29
LABORATORY INVESTIGATIONS
ABI <0.93 Conventional 
angiography
79.0 96.0 0.763 0.22 19.8 93923 $165.18
Duplex ultrasound8 Conventional 
angiography
87.6 (84.4-90.8) 94.7 (93.2-96.2) 0.729 0.13 16.5 93923 $165.18
Gadolinium-enhanced mag-
netic resonance angiography8
Conventional 
angiography
97.5 (95.7- 99.3) 96.2 (94.4-97.9) 0.807 0.03 25.7 73725 $504.00
ABI, ankle-brachial index; CI, confi dence interval; LR, likelihood ratio; PPV, positive predictive value. 
*Based on a prevalence of peripheral vascular disease of 14% (Pasternak RC et al1).
†  Based on estimated Medicare-approved CPT reimbursement rates, https://catalog.ama-assn.org/Catalog/cpt/cpt_search.jsp. Accessed December 2, 
2007. History and physical items based on a new-patient visit of moderate complexity, CPT Code 99203. Cost estimate for conventional invasive angi-
ography (angiography, extremity, unilateral, radiological supervision and interpretation, CPT Code 75710) $426.14 (Downstate Illinois estimates).
‡  Multiple criteria = segmental blood pressure, fl ow velocity by Doppler, postocclusive reactive hyperemia, pulse reappearance half-time, small or large-
vessel peripheral arterial disease, and surgery.
TABLE
patients or those with advanced diabetes, 
for whom the test is unreliable.11 ■
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